Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
CSafe Global Launches Real-Time Shipment Visibility for Passive Portfolios 2022-01-06 00:01
Tools4Patient Announces Name Change to Cognivia & Expands Board of Directors 2022-01-05 23:00
IMG Launches PTOgo, a New Travel Medical Product for Employers and Employees Traveling Abroad 2022-01-05 22:00
Insilico Medicine Announces the Nomination of Two Preclinical Candidates for PHD2, 12 Months After Program Initiation 2022-01-05 17:00
Antengene to Present at the 40th Annual J.P. Morgan Healthcare Conference 2022-01-05 12:50
Introducing Multilayer Clear Aligner Material: TRISTAR by Whitesmile Clear. 2022-01-05 12:00
IND Approved for Pivotal Clinical Study of HER2 Bispecific Antibody KN026 Combined with Chemotherapy in Gastric Cancer 2022-01-05 11:49
COVID-19 Oral Vaccine and Antibody Booster: B. subtilis Spores, Biotechnology Breakthrough by DreamTec 2022-01-05 10:00
SI GROUP APPOINTS RUSTOM JILLA AS NEW CHIEF FINANCIAL OFFICER 2022-01-05 02:00
CAI Announces CEO Succession 2022-01-04 22:33
Molecular Stethoscope, Inc. establishes new Corporate Headquarters and Research & Development Laboratories in South San Francisco and appoints Gajus Worthington to its Board of Directors 2022-01-04 19:00
Alamar Biosciences partners with Abcam to drive understanding of the human proteome 2022-01-04 17:00
Affiliates Flock to Seal Partnerships with Malaysia Healthcare at Expo 2020 Dubai 2022-01-04 15:32
Breakthrough Discoveries on Novel Features of Omicron Variant and An Anti-Omicron Antibody JMB2002 2022-01-04 10:00
Gannex Announces Completion of the U.S. Phase I Trial of ASC43F, an In-House Developed First-in-Class Dual Targeting Fixed-dose Combination Tablet for NASH 2022-01-04 08:30
Everest Medicines Announces Taiwan FDA Has Accepted New Drug Application for Sacituzumab Govitecan in Second-Line Metastatic Triple-Negative Breast Cancer 2022-01-04 08:00
Sihuan Pharmaceutical (0460.HK): Sunshine Life Insurance Leads Investment in Xuanzhu Biopharm 2022-01-03 14:24
Ascletis Expands Ritonavir Oral Tablet Production and Announces Oral Direct-Acting Antiviral Pipeline Against SARS-CoV-2 Virus 2022-01-03 08:30
CStone Pharmaceuticals announced the IND approval of CS5001, a potential global best-in-class ROR1-targeting ADC by the U.S. Food and Drug Administration 2022-01-03 08:00
Antengene Announces First Patient Dosed in REACH Study of ATG-016 for the Treatment of Advanced Solid Tumors 2021-12-30 09:51
1 247 248 249 250 251 742